Literature DB >> 33022468

Biocompatible fluorescent probe for detecting mitochondrial alkaline phosphatase activity in live cells.

Sabina Khatun1, Shayeri Biswas2, Arun Kumar Mahanta3, Manu M Joseph4, Murukan S Vidyalekshmi4, Arup Podder1, Pralay Maiti3, Kaustabh Kumar Maiti4, Sankarprasad Bhuniya5.   

Abstract

Alkaline phosphatase (ALP) is an enzyme that actively plays a significant role in the various metabolic processes by transferring a phosphate group to the protein, nucleic acid, etc. The elevated level of ALP in blood plasma is the hallmark of inflammation/cancer. The hyperactive mitochondria in cancer cells produce an excess of ATP to fulfill the high energy demand. Thus, we have developed a fluorescent probe Mito-Phos for ALP, which can detect phosphatase expression in mitochondria in live cells. The probe Mito-Phos has shown ~15-fold fluorescence intensity increments at 450 nm in the presence of 500 ng/mL of ALP. It takes about 60 min to consume the whole amount of ALP (500 ng/mL) in physiological buffer saline. It can selectively react with ALP even in the presence of other probable cellular reactive components. It is highly biocompatible and nontoxic to the live cells. It has shown ALP expression in a dose-dependent manner by providing concomitant fluorescence images in the blue-channel region. It has localized exclusively in the mitochondria in live cells. The probe Mito-Phos is highly biocompatible with the ability to assess ALP expression in mitochondria in live cells.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alkaline phosphatase; Cancer cells; Fluorescence; MTT assay; Mitochondria

Mesh:

Substances:

Year:  2020        PMID: 33022468     DOI: 10.1016/j.jphotobiol.2020.112043

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  1 in total

1.  Identification of MMP9 as a Novel Biomarker to Mitochondrial Metabolism Disorder and Oxidative Stress in Calcific Aortic Valve Stenosis.

Authors:  Cong Liu; Ruixue Liu; Zhezhe Cao; Qiao Guo; He Huang; Liangming Liu; Yingbin Xiao; Chenyang Duan; Ruiyan Ma
Journal:  Oxid Med Cell Longev       Date:  2022-09-24       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.